208 related articles for article (PubMed ID: 16482605)
1. p27 downregulation and metallothionein overexpression in gastric cancer patients are associated with a poor survival rate.
Galizia G; Ferraraccio F; Lieto E; Orditura M; Castellano P; Imperatore V; La Manna G; Pinto M; Ciardiello F; La Mura A; De Vita F
J Surg Oncol; 2006 Mar; 93(3):241-52. PubMed ID: 16482605
[TBL] [Abstract][Full Text] [Related]
2. Determination of molecular marker expression can predict clinical outcome in colon carcinomas.
Galizia G; Lieto E; Ferraraccio F; Orditura M; De Vita F; Castellano P; Imperatore V; Romano C; Ciardiello F; Agostini B; Pignatelli C
Clin Cancer Res; 2004 May; 10(10):3490-9. PubMed ID: 15161706
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of the cyclin-dependent kinase inhibitor p27Kip1 in gastric cancer.
Müller W; Grabsch H; Takeno S; Noguchi T; Hommel G; Gabbert HE
Anticancer Res; 2000; 20(3A):1787-92. PubMed ID: 10928108
[TBL] [Abstract][Full Text] [Related]
4. Expression of cell-cycle regulators p27 and cyclin E correlates with survival in gastric carcinoma patients.
So JB; Samarasinge K; Raju GC; Moochhala SM; Ti TK
J Surg Res; 2000 Nov; 94(1):56-60. PubMed ID: 11038303
[TBL] [Abstract][Full Text] [Related]
5. Expression of vascular endothelial growth factor (VEGF) and epidermal growth factor receptor (EGFR) is an independent prognostic indicator of worse outcome in gastric cancer patients.
Lieto E; Ferraraccio F; Orditura M; Castellano P; Mura AL; Pinto M; Zamboli A; De Vita F; Galizia G
Ann Surg Oncol; 2008 Jan; 15(1):69-79. PubMed ID: 17896140
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical expression of cell-cycle proteins in gastric precancerous lesions.
Anagnostopoulos GK; Stefanou D; Arkoumani E; Karagiannis J; Paraskeva K; Chalkley L; Habilomati E; Tsianos E; Agnantis NJ
J Gastroenterol Hepatol; 2008 Apr; 23(4):626-31. PubMed ID: 18397488
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of cell cycle regulator molecules in surgically resected stage I and II breast cancer.
Peters MG; Vidal Mdel C; Giménez L; Mauro L; Armanasco E; Cresta C; Bal de Kier Joffé E; Puricelli L
Oncol Rep; 2004 Nov; 12(5):1143-50. PubMed ID: 15492807
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical analysis of cell cycle-related molecules in gastric carcinoma: prognostic significance, correlation with clinicopathological parameters, proliferation and apoptosis.
Lee KH; Lee HE; Cho SJ; Cho YJ; Lee HS; Kim JH; Nam SY; Chang MS; Kim WH; Lee BL
Pathobiology; 2008; 75(6):364-72. PubMed ID: 19096232
[TBL] [Abstract][Full Text] [Related]
9. Expression of cell-cycle regulators, cyclin E and p21WAF1/CIP1, potential prognostic markers for gastric cancer.
Jang SJ; Park YW; Park MH; Lee JD; Lee YY; Jung TJ; Kim IS; Choi IY; Ki M; Choi BY; Ahn MJ
Eur J Surg Oncol; 1999 Apr; 25(2):157-63. PubMed ID: 10218458
[TBL] [Abstract][Full Text] [Related]
10. Low level of p27(Kip1) protein expression in gastric adenocarcinoma is associated with disease progression and poor outcome.
Nitti D; Belluco C; Mammano E; Marchet A; Ambrosi A; Mencarelli R; Segato P; Lise M
J Surg Oncol; 2002 Dec; 81(4):167-75; discussion 175-6. PubMed ID: 12451619
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of cyclin B1 in gastric cancer and its clinicopathological significance: an immunohistological study.
Yasuda M; Takesue F; Inutsuka S; Honda M; Nozoe T; Korenaga D
J Cancer Res Clin Oncol; 2002 Aug; 128(8):412-6. PubMed ID: 12200597
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of cell cycle protein expression in gastric cancer: cyclin B1 expression and its prognostic implication.
Begnami MD; Fregnani JH; Nonogaki S; Soares FA
Hum Pathol; 2010 Aug; 41(8):1120-7. PubMed ID: 20334896
[TBL] [Abstract][Full Text] [Related]
13. A study on the prognostic value of cyclins D1 and E expression levels in resectable gastric cancer and on some correlations between cyclins expression, histoclinical parameters and selected protein products of cell-cycle regulatory genes.
Tenderenda M
J Exp Clin Cancer Res; 2005 Sep; 24(3):405-14. PubMed ID: 16270527
[TBL] [Abstract][Full Text] [Related]
14. Combined evaluation of expressions of cyclin E and p53 proteins as prognostic factors for patients with gastric cancer.
Bani-Hani KE; Almasri NM; Khader YS; Sheyab FM; Karam HN
Clin Cancer Res; 2005 Feb; 11(4):1447-53. PubMed ID: 15746045
[TBL] [Abstract][Full Text] [Related]
15. Cell cycle dysregulation influences survival in high risk breast cancer patients.
Königsberg R; Rögelsperger O; Jäger W; Thalhammer T; Klimpfinger M; De Santis M; Hudec M; Dittrich C
Cancer Invest; 2008 Aug; 26(7):734-40. PubMed ID: 18665474
[TBL] [Abstract][Full Text] [Related]
16. pRb2/p130, vascular endothelial growth factor, p27(KIP1), and proliferating cell nuclear antigen expression in hepatocellular carcinoma: their clinical significance.
Claudio PP; Russo G; Kumar CA; Minimo C; Farina A; Tutton S; Nuzzo G; Giuliante F; Angeloni G; Maria V; Vecchio FM; Campli CD; Giordano A
Clin Cancer Res; 2004 May; 10(10):3509-17. PubMed ID: 15161709
[TBL] [Abstract][Full Text] [Related]
17. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
Ioachim E
Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
[TBL] [Abstract][Full Text] [Related]
18. Cyclin D3 expression in non-Hodgkin lymphoma. Correlation with other cell cycle regulators and clinical features.
Møller MB; Nielsen O; Pedersen NT
Am J Clin Pathol; 2001 Mar; 115(3):404-12. PubMed ID: 11242797
[TBL] [Abstract][Full Text] [Related]
19. Cyclin D2, but not cyclin D1, overexpression closely correlates with gastric cancer progression and prognosis.
Takano Y; Kato Y; Masuda M; Ohshima Y; Okayasu I
J Pathol; 1999 Oct; 189(2):194-200. PubMed ID: 10547574
[TBL] [Abstract][Full Text] [Related]
20. The immunohistochemical outline of p27kip1, cyclin B1 and cyclin D3 in pleomorphic adenomas.
Rullo R; Festa VM; Accardo M; Ferraraccio F
Minerva Stomatol; 2006 Sep; 55(9):483-92. PubMed ID: 17146427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]